The aim of this study is to establish a model for the evaluation of drug targets using postural measures to induce changes in lung water concentration as assessed by MRI. A reduction in the magnitude and rate of water transudation with postural changes in patients with congestive heart failure (CHF) could provide a model for the evaluation of various classes of molecules for target validation and for dose selection.
Study Type
INTERVENTIONAL
Allocation
NON_RANDOMIZED
Purpose
BASIC_SCIENCE
Masking
NONE
Enrollment
20
MRI of lungs to measure lung water content before and after passive leg raising (PLR)
GSK Investigational Site
London, United Kingdom
Lung water distribution as measured by MRI
MRI test
Time frame: Visit 1 and Visit 2 will be approximately 1 week apart
Lung water concentration as measured by MRI
MRI test
Time frame: Visit 1 and Visit 2 will be approximately 1 week apart
Between patient variability in lung water concentration as measured by MRI at 2 independent visits
MRI test
Time frame: Visit 1 and Visit 2 will be approximately 1 week apart
Within patient variability in lung water concentration as measured by MRI at 2 independent visits
MRI test
Time frame: Visit 1 and Visit 2 will be approximately 1 week apart
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.